Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Techno Medica Co., Ltd. ( (JP:6678) ) has shared an update.
For the nine months to December 31, 2025, Techno Medica lifted net sales 12.3% to ¥7.24 billion, boosting operating profit 41.9% to ¥829 million and ordinary profit 46.2% to ¥861 million, while net assets rose to ¥14.47 billion and the equity ratio strengthened to 85.4%; the company maintained its dividend plan of ¥68 per share for the fiscal year ending March 31, 2025.
The most recent analyst rating on (JP:6678) stock is a Buy with a Yen2622.00 price target. To see the full list of analyst forecasts on Techno Medica Co., Ltd. stock, see the JP:6678 Stock Forecast page.
More about Techno Medica Co., Ltd.
Techno Medica Co., Ltd., listed on the Tokyo Stock Exchange, operates in the medical devices and diagnostics segment, supplying instrumentation and systems for clinical laboratories and healthcare facilities in Japan.
Average Trading Volume: 6,661
Technical Sentiment Signal: Buy
Current Market Cap: Yen18.97B
See more insights into 6678 stock on TipRanks’ Stock Analysis page.